Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker

Heejung Chae(Ulsan College), Baek‐Yeol Ryoo(Asan Medical Center), Gi‐Won Song(Ulsan College), Dae Wook Hwang(Asan Medical Center), Se Jin Jang(University of Ulsan), Kyu‐pyo Kim(Ulsan College), Shin Hwang(Asan Medical Center), Deokhoon Kim(Ulsan College), Seung‐Mo Hong(Ulsan College), Song Cheol Kim(Ulsan College), Tae Jun Song, Changhoon Yoo(Ulsan College), Jae Hoon Lee(Ulsan College), Sang Soo Lee(Chungbuk National University Hospital), Jae Ho Jeong(Ulsan College), Chul Soo Ahn(Ulsan College), Tae Won Kim(Ulsan College), Heung-Moon Chang(Asan Medical Center), Do Hyun Park(Massachusetts Institute of Technology)
European Journal of Cancer
August 30, 2019
10.1016/j.ejca.2019.07.022
Cited by 98

Related Papers

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1.1k
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577